UK vaccine panel says under-30s should not receive Oxford/AstraZeneca vaccine
UK vaccine panel says under-30s should not receive Oxford/AstraZeneca vaccine
"Based on the available data and evidence, JCVI has advised that it is preferable for adults aged under 30 with no underlying conditions to be offered an alternative to the AstraZeneca vaccine where available," said Wei Shen Lim, COVID-19 Chair for JCVI.
(Reporting by Alistair Smout, Guy Faulconbridge and Kate
Holton; editing by James Davey)
((alistair.smout@thomsonreuters.com; +44 207 542 7064; Reuters
Messaging: alistair.smout.thomsonreuters.com@reuters.net)
LONDON, April 7 (Reuters) - Britain should not give Oxford University/AstraZeneca's vaccine to under 30s where possible, Britain's Joint Committee on Vaccination and Immunisation (JCVI) said on Wednesday, due to a very rare side effect of blood clots in the brain.
"Based on the available data and evidence, JCVI has advised that it is preferable for adults aged under 30 with no underlying conditions to be offered an alternative to the AstraZeneca vaccine where available," said Wei Shen Lim, COVID-19 Chair for JCVI.
(Reporting by Alistair Smout, Guy Faulconbridge and Kate
Holton; editing by James Davey)
((alistair.smout@thomsonreuters.com; +44 207 542 7064; Reuters
Messaging: alistair.smout.thomsonreuters.com@reuters.net)
伦敦，4月7日(路透社)-英国疫苗接种和免疫联合委员会(JCVI)周三表示，英国不应该在可能的情况下给30岁以下的人接种牛津大学/阿斯利康的疫苗，因为大脑中的血栓是非常罕见的副作用。JCVI新冠肺炎主席林伟(音译)表示：“根据现有的数据和证据，JCVI建议，对于30岁以下、没有潜在疾病的成年人，在可用的情况下，最好为他们提供阿斯利康疫苗的替代品。”(Alistair Smout，Guy Faulconbridge和Kate报道(Holton；James Davey编辑)(alistair.smout@thomsonreurs.com；+44 207 542 7064；路透社消息：alistair.smout.thomsonreuters.com@reuters.net)
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧